COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 458
[56] Vojdani A, Lambert J. The role of Th17 in neuroimmune
disorders: target for CAM therapy. Part I. Evid Based Complement
Alternat Med. 2011;2011:927294.
[57] Mitchell RH, Goldstein BI. Inflammation in children and
adolescents with neuropsychiatric disorders: a systematic review. J
Am Acad Child Adolesc Psychiatry. 2014;53(3):274-296.
[58] Verlaet AA, et al. Neuroinflammation and oxidative stress: a
vicious cycle in ADHD? Prog Neuropsychopharmacol Biol
Psychiatry. 2018;85:108-117.
[59] Blaylock RL. A possible central mechanism in autism spectrum
disorders, part 3: the role of excitotoxin food additives and the
synergistic effects of other environmental toxins. Altern Ther Health
Med. 2009;15(2):56-60.
[60] Petra AI, et al. Gut-microbiota-brain axis and its effect on
neuropsychiatric disorders with suspected immune dysregulation.
Clin Ther. 2015;37(5):984-995.
[61] Savitz JB, et al. Neuropsychiatric disorders: modulation by
microglia. Transl Psychiatry. 2015;5:e594.
[62] Morris G, et al. The emerging role of autoimmunity in myalgic
encephalomyelitis/chronic fatigue syndrome (ME/cfs). Mol
Neurobiol. 2014;49(2):741-756.
[63] Sotzny F, et al. Myalgic encephalomyelitis/chronic fatigue
syndrome - evidence for an autoimmune disease. Autoimmun
Rev. 2018;17(6):601-609.
[64] Loebel M, et al. Antibodies to ยด adrenergic and muscarinic
cholinergic receptors in patients with chronic fatigue syndrome.
Brain Behav Immun. 2016;52:32-39.
[65] Morris G, et al. Myalgic encephalomyelitis/chronic fatigue
syndrome: from pathophysiological insights to novel therapeutic
opportunities. Pharmacol Res. 2019;148:104450.
458
